200 related articles for article (PubMed ID: 25074869)
21. Use of proton pump inhibitors for the provision of stress ulcer prophylaxis: clinical and economic consequences.
Barletta JF; Sclar DA
Pharmacoeconomics; 2014 Jan; 32(1):5-13. PubMed ID: 24271943
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors for the prevention of stress-related mucosal disease in critically-ill patients: a meta-analysis.
Pongprasobchai S; Kridkratoke S; Nopmaneejumruslers C
J Med Assoc Thai; 2009 May; 92(5):632-7. PubMed ID: 19459523
[TBL] [Abstract][Full Text] [Related]
23. Stress ulcer prophylaxis versus placebo or no prophylaxis in adult hospitalised acutely ill patients-protocol for a systematic review with meta-analysis and trial sequential analysis.
Marker S; Perner A; Wetterslev J; Barbateskovic M; Jakobsen JC; Krag M; Granholm A; Anthon CT; Møller MH
Syst Rev; 2017 Jun; 6(1):118. PubMed ID: 28646925
[TBL] [Abstract][Full Text] [Related]
24. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
He N; Yan Y; Su S; Ge Q; Zhai S
Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
26. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.
Steinberg KP
Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662
[TBL] [Abstract][Full Text] [Related]
27. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
28. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
[TBL] [Abstract][Full Text] [Related]
29. Prophylactic acid suppressants in patients with primary neurologic injury: A systematic review and meta-analysis of randomized controlled trials.
Daou M; Dionne JC; Teng JFT; Taran S; Zytaruk N; Cook D; Wilcox ME
J Crit Care; 2022 Oct; 71():154093. PubMed ID: 35714455
[TBL] [Abstract][Full Text] [Related]
30. When should stress ulcer prophylaxis be used in the ICU?
Quenot JP; Thiery N; Barbar S
Curr Opin Crit Care; 2009 Apr; 15(2):139-43. PubMed ID: 19578324
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials.
Alhazzani W; Alshamsi F; Belley-Cote E; Heels-Ansdell D; Brignardello-Petersen R; Alquraini M; Perner A; Møller MH; Krag M; Almenawer S; Rochwerg B; Dionne J; Jaeschke R; Alshahrani M; Deane A; Perri D; Thebane L; Al-Omari A; Finfer S; Cook D; Guyatt G
Intensive Care Med; 2018 Jan; 44(1):1-11. PubMed ID: 29199388
[TBL] [Abstract][Full Text] [Related]
32. Stress-related mucosal bleeding in critically ill oncology patients.
Bruno JJ; Canada TW; Wakefield CD; Nates JL
J Oncol Pharm Pract; 2009 Mar; 15(1):9-16. PubMed ID: 18753185
[TBL] [Abstract][Full Text] [Related]
33. Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units.
Eastwood GM; Litton E; Bellomo R; Bailey MJ; Festa M; Beasley RW; Young PJ
Crit Care Resusc; 2014 Sep; 16(3):170-4. PubMed ID: 25161018
[TBL] [Abstract][Full Text] [Related]
34. Proton pump inhibitor therapy for peptic ulcer bleeding: Cochrane collaboration meta-analysis of randomized controlled trials.
Leontiadis GI; Sharma VK; Howden CW
Mayo Clin Proc; 2007 Mar; 82(3):286-96. PubMed ID: 17352364
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
Barkun AN; Adam V; Martel M; Bardou M
Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
[TBL] [Abstract][Full Text] [Related]
36. Risks and benefits of stress ulcer prophylaxis in adult neurocritical care patients: a systematic review and meta-analysis of randomized controlled trials.
Liu B; Liu S; Yin A; Siddiqi J
Crit Care; 2015 Nov; 19():409. PubMed ID: 26577436
[TBL] [Abstract][Full Text] [Related]
37. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
Avendaño-Reyes JM; Jaramillo-Ramírez H
Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
[TBL] [Abstract][Full Text] [Related]
38. Proton Pump Inhibitors Versus Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients: A Meta-analysis and Trial Sequential Analysis.
Deliwala SS; Hamid K; Goyal H; Ponnapalli A; Zayed Y; Bala A; Lakshman H; Malladi S; Jones S; Santana M; Leon B; An MT; Chawla S
J Clin Gastroenterol; 2022 Mar; 56(3):204-217. PubMed ID: 34049377
[TBL] [Abstract][Full Text] [Related]
39. Stress ulcer prophylaxis with proton pump inhibitors or histamin-2 receptor antagonists in adult intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
Barbateskovic M; Marker S; Granholm A; Anthon CT; Krag M; Jakobsen JC; Perner A; Wetterslev J; Møller MH
Intensive Care Med; 2019 Feb; 45(2):143-158. PubMed ID: 30680444
[TBL] [Abstract][Full Text] [Related]
40. Q: do all hospitalized patients need stress ulcer prophylaxis?
Eisa N; Bazerbachi F; Alraiyes AH; Alraies MC
Cleve Clin J Med; 2014 Jan; 81(1):23-5. PubMed ID: 24391103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
